Jorge Fernandez-de-Cossio

Dr. Jorge Fernandez-de-Cossio

orcid

Research Focus & Metrics

Academic Career Length

23Years (2004-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
17 February 2010 in BMC Bioinformatics
Verified
Journal Article
Open access
PDF file
AMAlexander Martin
Alexander Martin
MOMaria E Ochagavia
Maria E Ochagavia
LRLaya C Rabasa
Laya C Rabasa
JMJamilet Miranda
Jamilet Miranda
JFJorge Fernandez-de-Cossio
Jorge Fernandez-de-Cossio
RBRicardo Bringas
Ricardo Bringas
Background: The increasing availability and diversity of omics data in the post-genomic era offers new perspectives in most areas of biomedical research. Graph-based biological networks models capture the topology of the functional relationships between molecular entities such as gene, protein and small compounds and provide a suitable framework for integrating and analyzing omics-data. The development of software tools capable of integrating data from different sources and to provide flexible methods to reconstruct, represent and analyze topological networks is an active field of research in bioinformatics. Results: BisoGenet is a multi-tier application for visualization and analysis of biomolecular relationships. The system consists of three tiers. In the data tier, an in-house database stores genomics information, protein-protein interactions, protein-DNA interactions, gene ontology and metabolic pathways. In the middle tier, a global network is created at server startup, representing the whole data on bioentities and their relationships retrieved from the database. The client tier is a Cytoscape plugin, which manages user input, communication with the Web Service, visualization and analysis of the resulting network. Conclusion: BisoGenet is able to build and visualize biological networks in a fast and user-friendly manner. A feature of Bisogenet is the possibility to include coding relations to distinguish between genes and their products. This feature could be instrumental to achieve a finer grain representation of the bioentities and their relationships. The client application includes network analysis tools and interactive network expansion capabilities. In addition, an option is provided to allow other networks to be converted to BisoGenet. This feature facilitates the integration of our software with other tools available in the Cytoscape platform. BisoGenet is available at http://bio.cigb.edu.cu/bisogenet-cytoscape/.

21 September 2004 in Rapid Communications in Mass Spectrometry
Verified
Journal Article
Closed access
PDF file
JFJorge Fernandez-de-Cossio
Jorge Fernandez-de-Cossio
LGLuis Javier Gonzalez
Luis Javier Gonzalez
YSYoshinori Satomi
Yoshinori Satomi
LBLazaro Betancourt
Lazaro Betancourt
YRYassel Ramos
Yassel Ramos
TTToshifumi Takao
Toshifumi Takao

1 July 2004 in Nucleic Acids Research
Verified
Journal Article
Open access
PDF file
JFJorge Fernandez-de-Cossio
Jorge Fernandez-de-Cossio
LGLuis Javier Gonzalez
Luis Javier Gonzalez
YSYoshinori Satomi
Yoshinori Satomi
LBLazaro Betancourt
Lazaro Betancourt
YRYassel Ramos
Yassel Ramos
TTToshifumi Takao
Toshifumi Takao
The web application Isotopica has been developed as an aid to the interpretation of ions that contain naturally occurring isotopes in a mass spectrum. It allows the calculation of mass values and isotopic distributions based on molecular formulas, peptides/proteins, DNA/RNA, carbohydrate sequences or combinations thereof. In addition, Isotopica takes modifications of the input molecule into consideration using a simple and flexible language as a straightforward extension of the molecular formula syntax. This function is especially useful for biomolecules, which are often subjected to additional modifications other than normal constituents, such as the frequently occurring post-translational modification in proteins. The isotopic distribution of any molecule thus defined can be calculated by considering full widths at half maximum or mass resolution. The combined envelope of several overlapping isotopic distributions of a mixture of molecules can be determined after specifying each molecule's relative abundance. The results can be displayed graphically on a local PC using the Isotopica viewer, a standalone application that is downloadable from the sites below, as a complement to the client browser. The m/z and intensity values can also be obtained in the form of a plain ASCII text file. The software has proved to be useful for peptide mass fingerprinting and validating an observed isotopic ion distribution with reference to the theoretical one, even from a multi-component sample. The web server can be accessed at http://bioinformatica.cigb.edu/isotopica and http://coco.protein.osaka-u.ac.jp/isotopica.


20 December 2021 in Molecular Medicine
Verified
Journal Article
Open access
PDF file
JMJamilet Miranda
Jamilet Miranda
RBRicardo Bringas
Ricardo Bringas
JFJorge Fernandez-de-Cossio
Jorge Fernandez-de-Cossio
YNYasser Perera Negrin
Yasser Perera Negrin
Background: Similarities in the hijacking mechanisms used by SARS-CoV-2 and several types of cancer, suggest the repurposing of cancer drugs to treat Covid-19. CK2 kinase antagonists have been proposed for cancer treatment. A recent study in cells infected with SARS-CoV-2 found a significant CK2 kinase activity, and the use of a CK2 inhibitor showed antiviral responses. CIGB-300, originally designed as an anticancer peptide, is an antagonist of CK2 kinase activity that binds to the CK2 phospho-acceptor sites. Recent preliminary results show the antiviral activity of CIGB-300 using a surrogate model of coronavirus. Here we present a computational biology study that provides evidence, at the molecular level, of how CIGB-300 may interfere with the SARS-CoV-2 life cycle within infected human cells. Methods: Sequence analyses and data from phosphorylation studies were combined to predict infection-induced molecular mechanisms that can be interfered by CIGB-300. Next, we integrated data from multi-omics studies and data focusing on the antagonistic effect on the CK2 kinase activity of CIGB-300. A combination of network and functional enrichment analyses was used. Results: Firstly, from the SARS-CoV studies, we inferred the potential incidence of CIGB-300 in SARS-CoV-2 interference on the immune response. Afterwards, from the analysis of multiple omics data, we proposed the action of CIGB-300 from the early stages of viral infections perturbing the virus hijacking of RNA splicing machinery. We also predicted the interference of CIGB-300 in virus-host interactions that are responsible for the high infectivity and the particular immune response to SARS-CoV-2 infection. Furthermore, we provided evidence of how CIGB-300 may participate in the attenuation of phenotypes related to muscle, bleeding, coagulation and respiratory disorders. Conclusions: Our computational analysis proposes putative molecular mechanisms that support the antiviral activity of CIGB-300.

8 July 2010 in Analytical Chemistry
Verified
Journal Article
Closed access
JFJorge Fernandez-de-Cossio
Jorge Fernandez-de-Cossio